The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

Telemedicine company Hims & Hers has hired Farshad Shadloo to lead communications. As VP of communications, Shadloo reports ...

Hers is a relatively new telehealth platform that offers prescription medications and customized support for weight loss. The ...

Hims & Hers stock took a nosedive after Cigna’s Evernorth division announced a $200 monthly cap on popular weight-loss drugs ...

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna ...

Hims & Hers Health, Inc. (NYSE: HIMS) today announced eligible customers can access 6 months of prescription-only Wegovy® at ...

Hims & Hers Health, Inc (NYSE:HIMS) is facing heavy selling pressure Thursday morning as the U.S. Food and Drug Administration's (FDA) ban of compounded drugs with semaglutide takes effect.

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at ...

Longevity startups have become trendy in digital health, drawing attention from celebrity and established investors.

WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn't adapt fast enough to a rapidly ...

Online health and wellness company Hims & Hers raised $1 billion through convertible senior notes to grow its international ...